Cited by 173Neurogenesis and neuroplasticity mechanismsGenomic variations and chromosomal abnormalitiesGenetics and Neurodevelopmental Disorders

Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome

Open access
Meechan, Daniel W., Tucker, Eric S., Maynard, Thomas M., LaMantia, Anthony-Samuel·2009·Proceedings of the National Academy of Sciences

Abstract

The 22q11 deletion (or DiGeorge) syndrome (22q11DS), the result of a 1.5- to 3-megabase hemizygous deletion on human chromosome 22, results in dramatically increased susceptibility for “diseases of cortical connectivity” thought to arise during development, including schizophrenia and autism. We show that diminished dosage of the genes deleted in the 1.5-megabase 22q11 minimal critical deleted region in a mouse model of 22q11DS specifically compromises neurogenesis and subsequent differentiation in the cerebral cortex. Proliferation of basal, but not apical, progenitors is disrupted, and subsequently, the frequency of layer 2/3, but not layer 5/6, projection neurons is altered. This change is paralleled by aberrant distribution of parvalbumin-labeled interneurons in upper and lower cortical layers. Deletion of Tbx1 or Prodh (22q11 genes independently associated with 22q11DS phenotypes) does not similarly disrupt basal progenitors. However, expression analysis implicates additional 22q11 genes that are selectively expressed in cortical precursors. Thus, diminished 22q11 gene dosage disrupts cortical neurogenesis and interneuron migration. Such developmental disruption may alter cortical circuitry and establish vulnerability for developmental disorders, including schizophrenia and autism.

Integrity signals

Registry

Crossref · 10.1073/pnas.0905696106

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Gene sets involved in cell and neuronal development and function (including projection, motility and proliferation) previously reported in ASD-associated phenotypes were identified.

    “For example, gene sets involved in cell and neuronal development and function (including projection, motility and proliferation) previously reported in ASD-associated phenotypes were identified 24 .”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Meechan, D. W., Tucker, E. S., Maynard, T. M., & LaMantia, A.-S.
Affiliations
  • University of North Carolina at Chapel Hill (US)
  • Department of Cell and Molecular Physiology and
Venue
Proceedings of the National Academy of Sciences
Published
2009-09-22
Volume
106
Issue
38
Pages
16434-16445
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1985400815
Cited by
173
References
54
Citations by year
2026: 8 · 2025: 8 · 2024: 2 · 2023: 11 · 2022: 6 · 2021: 6 · 2020: 12 · 2019: 8 · 2018: 3 · 2017: 10 · 2016: 10 · 2015: 9 · 2014: 13 · 2013: 25 · 2012: 13
FWCI
4.39
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • UNC Libraries
Funders
  • National Institute of Mental Health (MH-64065, P50MH064065)
  • National Institute of Neurological Disorders and Stroke (NS-031768, R01NS031768)
  • National Institute of Child Health and Human Development (HD042182)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD029178, R01HD029178, R29HD029178, R01HD042182, HD042182)
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
22q11.2 deletion syndrome, neurogenesis, cortical development, gene dosage, basal progenitors, apical progenitors, projection neurons, interneuron migration, parvalbumin interneurons, cortical layers, Tbx1, proline dehydrogenase, schizophrenia, autism spectrum disorder, mouse model
MeSH terms
Animals, Cell Differentiation, Cerebral Cortex, Chromosome Deletion, Chromosomes, Human, Pair 21, DiGeorge Syndrome, Disease Models, Animal, Histones, Humans, Immunohistochemistry, Mice, Inbred C57BL, Phosphoproteins, Mice, Knockout, Gene Expression Regulation, Developmental, Cell Cycle Proteins, Cyclin D1, Reverse Transcriptase Polymerase Chain Reaction, T-Box Domain Proteins, Synteny, Chromosomes, Mammalian, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review